Advanced manufacturing for biodegradable microfluidic diagnostic devices

该项目旨在使更多的实验室质量测试在护理点成功商业化，同时将其一次性组件的环境影响降至最低。微流控技术使高质量的实验室分析能够转移到护理点测试设备中。这些测试使传染病检测(如新冠肺炎)或慢性病监测(如糖尿病、慢性心脏病等)具有高质量的分子、免疫分析和临床化学分析，可由家庭、工作或医护人员环境中的任何人完成。由于产品开发和建立大批量生产线所需的大量投资和上市时间，这种微流控技术的快速采用受到了阻碍。Device Scope旨在通过开发一种使用可生物降解材料的微流控设备的新制造系统，显著提高微流控诊断产品的商业化程度，同时将这些一次性测试对环境的影响降至最低。该项目将使用我们独特的制造技术对可生物降解材料进行评估，并随后建造用于评估的原型微流控设备。

This project aims to enable the successful commercialisation of more lab-quality tests at the Point-of-Care whilst minimising the environmental impact of their disposable components.Microfluidic technology enables the transfer of high-quality lab assays into Point-of-Care testing devices. These tests enable infectious disease detection (e.g. Covid-19) or chronic disease monitoring (e.g. diabetes, chronic heart disease, etc) with high quality molecular, immunoassay and clinical chemistry assays to be completed by anyone in the home, work or health care worker setting. Fast uptake of this microfluidic technology has been hindered by the significant investments and time to market required for the product development and establishment of high-volume manufacturing lines.Device Scope aims to dramatically improve the commercialisation of microfluidic diagnostic products whilst minimising the impact of these disposable tests on the environment by developing a new manufacturing system for microfluidic devices that utilises biodegradable materials. This project will assess the biodegradable material using our unique manufacturing techniques and subsequently build prototype microfluidic devices for assessment.